NeuroSense Therapeutics
is targeting multiple key pathways in als | NeuroSense Therapeutics
Company
Deck Type
Sector
Industry
Deck date
October 2024
Slide
8 of 27
Related slides by other companies
Sema4
SPAC
August 2021
best in class solutions across multiple key areas | Sema4
Talkspace
Investor Conference
January 2022
key | Talkspace
Boundless Bio
IPO
March 2024
driving a new treatment paradigm by targeting pathways that enable tumor evolution and resistance traditional targeted therapy game over | Boundless Bio
Other recent decks by NeuroSense Therapeutics
See all presentations (4 decks)
Investor Presentation
January 2024
Investor Presentation
December 2023
Investor Presentation
June 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights